Proteomics International Laboratories has received a milestone seal of approval for its...
PromarkerD Hits Latin America
Proteomics International is pleased to announce that the company’s PromarkerD test for kidney disease is set to improve the lives of diabetics in Latin America with a new million dollar deal to commercialise the test in the region.